SCHEMBL4266798

SCHEMBL4266798

O=C(O)c1cc(Br)c(C(=O)OC(=O)c2c(Br)cc(C(=O)O)c3c(C(=O)O)c(Br)cc(C(=O)O)c23)c2c(C(=O)O)cc(Br)c(C(=O)O)c12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.38
FYN P06241 1/20 0.38
AKR1C3 P42330 3/20 0.36
AKR1C4 P17516 2/20 0.36
AKR1C2 P52895 2/20 0.36
AKR1C1 Q04828 2/20 0.36
HSD17B10 Q99714 2/20 0.36
TSHR P16473 1/20 0.35
PTPN1 P18031 2/20 0.33
CA12 O43570 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA3 P07451 1/20 0.33
CA4 P22748 1/20 0.33
CA6 P23280 1/20 0.33
CA5A P35218 1/20 0.33
CA7 P43166 1/20 0.33
CA9 Q16790 1/20 0.33
CA13 Q8N1Q1 1/20 0.33
CA14 Q9ULX7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3664560 0.88 AKR1C3 (0.43) LCKFYNAKR1C3AKR1C4AKR1C2
SCHEMBL19582619 0.82 CYP1A2 (0.44) LCKFYNAKR1C3AKR1C4AKR1C2
SCHEMBL3868457 0.81 CYP1A2 (0.56) LCKFYNAKR1C3AKR1C4AKR1C2
SCHEMBL27895950 0.76 CA12 (0.36) LCKFYNAKR1C3AKR1C4AKR1C2
SCHEMBL6738393 0.74 ALDH1A1 (0.37) AKR1C3AKR1C4AKR1C2AKR1C1HSD17B10
SCHEMBL17512444 0.73 LCK (0.33) LCKFYNAKR1C3AKR1C4AKR1C2
SCHEMBL28180752 0.71 CYP1A2 (0.44) LCKFYNAKR1C3AKR1C4AKR1C2
SCHEMBL4830420 0.70 PRNP (0.45) AKR1C3AKR1C4AKR1C2AKR1C1HSD17B10
SCHEMBL8941154 0.70 AKR1C4 (0.42) LCKFYNAKR1C3AKR1C4AKR1C2
SCHEMBL6735101 0.69 ALDH1A1 (0.36) AKR1C3AKR1C4AKR1C2AKR1C1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109354674-B Semi-fluoroalkyl dovetail side chain substituted naphthalene diimide-based copolymer, preparation method and application thereof 北京印刷学院 2021-02-02 CN claimed
US-11114251-B2 Polymer, method for preparing the same and solar cell comprising the polymer BOE TECHNOLOGY GROUP CO., LTD. (CN) 2021-09-07 US disclosed
CN-109354674-B Semi-fluoroalkyl dovetail side chain substituted naphthalene diimide-based copolymer, preparation method and application thereof 北京印刷学院 2021-02-02 CN disclosed
CN-107556461-B Polymer, preparation method thereof and solar cell 京东方科技集团股份有限公司 2019-12-06 CN disclosed
US-7605263-B2 Fluorescent naphthalene-1,4,5,8-tetracarboxylic bisimides with an electron-donating substituent on the nucleus INFINEON TECHNOLOGIES AG (DE) 2009-10-20 US disclosed
US-20030153005-A1 Fluorescent naphthalene -1,4,5,8-tetracarboxylic bisimides with an electron-donating substituent on the nucleus POLARIS INNOVATIONS LIMITED (IE) 2003-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153005-A1 Fluorescent naphthalene -1,4,5,8-tetracarboxylic bisimides with an electron-donating substituent on the nucleus H1-4, H1-3, H1-5 LCK 2926/4885FYN 3088/4885AKR1C3 790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.